Kronox Lab Sciences Limited (NSE:KRONOX)
India · Delayed Price · Currency is INR 195.10
+4.86 (2.55%)
Nov 12, 2026, 3:29 PM IST
Kronox Lab Sciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 7,239 | 3,600 | 5,323 | - | - | - | |
Market Cap Growth | 30.96% | -32.38% | - | - | - | - |
Enterprise Value | 6,444 | 3,104 | 5,129 | - | - | - |
Last Close Price | 190.24 | 96.74 | 142.64 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 25.55 | 13.02 | 20.90 | - | - | - |
PS Ratio | 6.70 | 3.56 | 5.31 | - | - | - |
PB Ratio | 5.60 | 3.10 | 5.91 | - | - | - |
P/TBV Ratio | 5.60 | 3.10 | 5.91 | - | - | - |
P/FCF Ratio | 26.20 | 17.49 | 19.29 | - | - | - |
P/OCF Ratio | 24.33 | 15.07 | 17.34 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 5.96 | 3.07 | 5.12 | - | - | - |
EV/EBITDA Ratio | 17.86 | 8.95 | 15.33 | - | - | - |
EV/EBIT Ratio | 18.93 | 9.48 | 15.93 | - | - | - |
EV/FCF Ratio | 23.29 | 15.08 | 18.59 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | - | 0.01 | - | - | - | 0.08 |
Debt / EBITDA Ratio | - | 0.05 | - | - | - | 0.17 |
Debt / FCF Ratio | - | 0.08 | - | - | - | 0.64 |
Net Debt / Equity Ratio | -0.62 | -0.41 | -0.41 | -0.22 | -0.13 | -0.16 |
Net Debt / EBITDA Ratio | -2.23 | -1.36 | -1.10 | -0.50 | -0.26 | -0.35 |
Net Debt / FCF Ratio | -2.91 | -2.29 | -1.33 | -2.80 | -0.50 | -1.27 |
Asset Turnover | 0.85 | 0.89 | 1.16 | 1.40 | 1.73 | 1.75 |
Inventory Turnover | 6.71 | 6.38 | 6.39 | 5.02 | 6.62 | 7.34 |
Quick Ratio | 9.88 | 6.74 | 6.51 | 4.76 | 2.84 | 2.62 |
Current Ratio | 10.75 | 7.61 | 7.28 | 6.08 | 3.89 | 3.21 |
Return on Equity (ROE) | 24.70% | 26.82% | 32.56% | 38.45% | 38.55% | 40.58% |
Return on Assets (ROA) | 16.76% | 18.08% | 23.29% | 26.73% | 23.11% | 23.95% |
Return on Invested Capital (ROIC) | 42.57% | 39.67% | 45.43% | 44.90% | 41.88% | 45.11% |
Return on Capital Employed (ROCE) | 26.20% | 27.90% | 35.70% | 41.30% | 45.30% | 42.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 3.91% | 7.68% | 4.78% | - | - | - |
FCF Yield | 3.82% | 5.72% | 5.18% | - | - | - |
Dividend Yield | 0.26% | 0.52% | 0.35% | - | - | - |
Payout Ratio | 6.56% | 6.71% | 7.28% | - | - | - |
Buyback Yield / Dilution | -0.01% | - | - | 4.09% | 0.91% | 3.59% |
Total Shareholder Return | 0.25% | 0.52% | 0.35% | 4.09% | 0.91% | 3.59% |